Skip to main content
Kidney International Supplements logoLink to Kidney International Supplements
. 2017 Nov 17;7(3):e1. doi: 10.1016/j.kisu.2017.10.001

Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59

PMCID: PMC6341011  PMID: 30681074

The above-mentioned article has the following corrections.

In Supplementary Table S21, the treatment agent under Arm 2 for both Di Iorio 2012 and Di Iorio 2013 studies should be calcium carbonate and not calcium acetate as stated. Supplemental Table S21 has now been amended in the online supplemental file. The conclusions from the Work Group remain unchanged.


Articles from Kidney International Supplements are provided here courtesy of Elsevier

RESOURCES